Investigating treatments for stimulant use disorders like cocaine and methamphetamine addiction
Short-term Outcome of Stimulant Use Disorder Treatment Trials
This study is looking at how well different treatments help people with cocaine and methamphetamine addiction by focusing on their cravings, to find out which medications might work best for lasting recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11046075 on NIH RePORTER |
What this research studies
This research focuses on understanding the short-term outcomes of treatments for stimulant use disorders, particularly cocaine and methamphetamine addiction. It aims to explore drug craving as a key outcome, which is often linked to relapse in users. By analyzing data from previous short-term trials, the study seeks to identify effective medications that could lead to longer-term solutions. Patients may be monitored for their cravings and responses to various treatment approaches over a specified period.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with stimulant use disorders, particularly those using cocaine or methamphetamine.
Not a fit: Patients who are not currently experiencing stimulant use disorders or those who have not engaged in stimulant use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective medications for treating stimulant use disorders, improving recovery outcomes for patients.
How similar studies have performed: While there have been numerous trials on stimulant use disorders, this specific focus on craving as a primary outcome is relatively novel and has not been extensively tested.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Mojtabai, Ramin — Tulane University of Louisiana
- Study coordinator: Mojtabai, Ramin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.